Fundz

Genetesis Announces Close Of $17.5 Million Series C Financing

PRIVATEOct 06, 2022

Amount Raised

$17.5 Million

Round Type

Series C

MasonBiotechnologyHealth Care

Description

Genetesis, the market leader in next-generation biomagnetic imaging, has announced that it has closed $17.5 million in Series C Financing. The round was led by Mithril Capital with participation from Cercano Management as well as from existing investors, including JobsOhio Growth Capital, Ohio Innovation Fund and CincyTech. This investment brings the company’s total funding to over $40 million.

Quick answer

Genetesis raised $17.5 Million in a Series C round, dated October 6, 2022. Genetesis is based in Mason, Texas, United States.

How much did Genetesis raise?
Genetesis raised $17.5 Million in a Series C round on October 6, 2022.
What does Genetesis do?
Genetesis is a rapidly growing medical imaging company leveraging data science and biomagnetism in the fight against cardiovascular disease
Where is Genetesis based and how big is it?
Genetesis is based in Mason, Texas, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Genetesis that raised within 45 days of this round, from Fundz verified event records.

  • Arialys Therapeutics raised $14M on November 18, 2022.
  • Venus Concept Inc. raised $6.7M on November 18, 2022.
  • MedX Health raised an undisclosed amount (Convertible Note) on November 18, 2022.
  • SCA Health raised $18K (Pre-Seed) on November 18, 2022.
  • Streamex Corp. raised $1.5M (Seed) on November 18, 2022.
  • Mediar Therapeutics raised $32M on November 18, 2022.

Who to call at Genetesis, and when

A new round usually means Genetesis is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Genetesis raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Genetesis, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Genetesis. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Genetesis

Location

Mason, Texas, United States

About

Genetesis is a rapidly growing medical imaging company leveraging data science and biomagnetism in the fight against cardiovascular disease

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Genetesis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Genetesis's next move

See what Strategic adds

Genetesis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.